American Society of Hematology

You must select a month AND year to filter.

IMMEDIATE ACTION NEEDED: Contact Your Senators and Representative to Support Legislation to Combat Drug Shortages
May 18, 2012
Legislation to address drug shortages has been moving through the House of Representatives and the U.S Senate. The Senate is expected to vote on its bill Monday, May 21 and the House of Representatives is planning to vote May 30.

Report Urges Increase In NIH Budget to Keep U.S. Ahead in Biomed
May 18, 2012
The Chinese government plans to invest $309 billion in biotechnology over the next five years, twice the amount the U.S. government will spend on biomedical research over that period if current trends hold, a new report says.

ASH Urges Congress to Restore Salary Limit Imposed on Extramural NIH Researchers
May 17, 2012
ASH joined with 161 organizations to urge Congress to restore the salary limit imposed on extramural NIH researchers to Level I of the Executive pay scale.

Senate Likely to Take Up FDA Bill on User Fee Programs & Drug Shortages May 21
May 16, 2012
Legislation concerning Food and Drug Administration user fee programs and drug shortages is picking up speed with the Senate planning to start consideration the week of May 21 and the House of Representatives considering its version after Memorial Day.

NCATS Launches Collaborative Program with Industry and Researchers to Spur Therapeutic Development, Seeks Feedback
May 8, 2012
The National Institutes of Health (NIH) unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients.

Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets
May 7, 2012
A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of patients with low platelet counts and a risk of bleeding due to chronic immune thrombocytopenic purpura (ITP). In study results published online today in Blood, the Journal of the American Society of Hematology (ASH), investigators at Weill Cornell Medical College provide the very first long-term outcome data for patients with chronic ITP treated with rituxamab.

Researchers Rejuvenate Blood-Forming Stem Cells in Mice (HealthDay News)
May 7, 2012
Researchers who found a way to rejuvenate aged blood-forming cells in mice say their achievement offers clues about how it may be possible to combat health problems associated with old age.

Implementation of Sunshine Act Delayed
May 7, 2012
Included in the Patient Protection and Affordable Care Act (PPACA) is a provision that will require drug and medical device companies to begin recording any physician payments that are worth more than $10 in 2012 and to report and make public on the Web.

NIH Launches Collaborative Program with Industry and Researchers to Spur Therapeutic Development (NIH News)
May 3, 2012
The National Institutes of Health today unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients. NIH's new National Center for Advancing Translational Sciences (NCATS) has partnered initially with Pfizer, AstraZeneca, and Eli Lilly and Company which have agreed to make dozens of their compounds available for this initiative's pilot phase.

ASH Comments to House Energy and Commerce Committee Re: Drug Shortage Provisions in PDUFA/MDUFMA
May 3, 2012
The American Society of Hematology (ASH) appreciates the opportunity to submit comments regarding the drug shortage provisions included in the House Committee on Energy and Commerce's draft Prescription Drug User Fee Act (PDUFA) and Medical Device User Fee and Modernization Act (MDUFMA) legislation.

ASH Advocacy to Combat Drug Shortages Making a Difference; Language Included in Senate Appropriations Report
May 3, 2012
The Senate Appropriations Committee approved the FY 2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill on April 26.

Obama Administration Unveils Bioeconomy Blueprint, Calls for Acceleration of Non-Embryonic Stem Cell Research for Treatment of Blood Diseases
May 1, 2012
The White House released a “Bioeconomy Blueprint” last week outlining an approach to harness innovations and address national challenges in health, food, energy and the environment. The Blueprint is designed to guide work among federal agencies and with the private-sector to enhance economic growth, job creation, and innovation.